Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released Aug 8, 2022, after the close
10-Q filed Aug 9, 2022, 40 days after period end · 0000950170-22-015642
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Revenue | $134.56M | $115.22M | $110.10M | $83.21M |
| Net Income | -$34.01M | -$43.87M | -$42.14M | -$54.94M |
| EPS Diluted |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.21 |
| -$0.27 |
| -$0.27 |
| -$0.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
